KEY FIGURES OF THE GALENICA GROUP

in million CHF

2015

2014

Net sales

3,791.6

3,416.3

Vifor Pharma

967.0

706.2

Galenica Santé

2,891.3

2,781.9

- Health & Beauty

1,396.7

1,297.1

- Services

2,224.6

2,151.6

- Eliminations Galenica Santé

(730.0)

(666.8)

Corporate and Eliminations

(66.7)

(71.8)

EBITDA

537.4

446.8

EBITDA in % of net sales

14.2 %

13.1 %

EBIT

450.8

370.2

Vifor Pharma

333.0

265.0

Galenica Santé

125.2

102.9

- Health & Beauty

84.5

66.6

- Services

37.1

34.9

- Eliminations Galenica Santé

3.6

1.4

Corporate and Eliminations

(7.4)

2.3

EBIT in % of net sales

11.9 %

10.8 %

Net profit

370.0

312.0

- Attributable to shareholders of Galenica Ltd.

301.1

284.5

- Share of minority interests

68.9

27.5

in million CHF

2015

2014

Investment in property, plant and equipment and intangible assets

368.61)

70.0

Investment in research and development

88.8

104.2

Employees at reporting date (FTE)

6,421

6,348

Cash flow from operating activities

522.2

355.8

Total assets

3,640.0

3,208.3

Shareholders' equity

1,976.2

1,750.5

Equity ratio

54.3 %

54.6 %

Net debt

159.1

341.1

Gearing

8.1 %

19.5 %

1) Including upfront and milestone payments of CHF 290.4 million from licensing agreements

Contact

Galenica Ltd.

Untermattweg 8
CH-3027 Bern

Phone:
+41 58 852 81 11
Fax:
+41 58 852 81 12

Send link

Send as link



Links